High-dose chemotherapy with autologous hematopoietic stem cell support versus: standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial

被引：0
|
作者：
Zander, AR
Kroeger, N
Schmoor, C
Krueger, W
Moebus, V
Frickhofen, N
Metzner, B
Schultze, W
Berdel, WE
Koenigsmann, M
Wandt, H
Possinger, K
Truemper, L
Pflueger, KH
Kreienberg, R
Carstensen, M
Franke, A
Schmidt, EH
Jaenicke, F
Hossfeld, DK
Schumacher, M
Jonat, W
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S34 / S34
页数：1
相关论文
共 50 条
  • [21] High-dose chemotherapy with autologous stem-cell support versus standard-dose chemotherapy: meta-analysis of individual patient data from 6 randomised metastatic breast cancer trials
    Demirer, T.
    Ueno, N.
    Johnson, M.
    Bregni, M.
    Berry, D. A.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S16 - S16
  • [22] High-dose chemotherapy and autologous stem cell transplantation for breast cancer
    Baynes, RD
    Dansey, RD
    Klein, JL
    Karanes, C
    Cassells, L
    Abella, E
    Wei, WZ
    Galy, A
    Du, W
    Wood, G
    Peters, WP
    CANCER INVESTIGATION, 2000, 18 (05) : 440 - 455
  • [23] High-dose chemotherapy with autologous stem cell rescue in breast cancer
    Dillman, RO
    Barth, NM
    Nayak, SK
    DeLeon, C
    OConnor, A
    Morrelli, L
    BREAST CANCER RESEARCH AND TREATMENT, 1996, 37 (03) : 277 - 289
  • [24] High-dose chemotherapy with autologous stem cell support in patients with responding stage IV breast cancer
    P Ljungman
    B Björkstrand
    T Fornander
    M Höglund
    G Juliusson
    H Lindman
    A Malmström
    S Rotstein
    M Söderberg
    N Wilking
    K Villman
    J Bergh
    Bone Marrow Transplantation, 1998, 22 : 445 - 448
  • [25] High-dose chemotherapy with autologous stem cell support in patients with responding stage IV breast cancer
    Ljungman, P
    Björkstrand, B
    Fornander, T
    Höglund, M
    Juliusson, G
    Lindman, H
    Malmström, A
    Rotstein, S
    Söderberg, M
    Wilking, N
    Villman, K
    Bergh, J
    BONE MARROW TRANSPLANTATION, 1998, 22 (05) : 445 - 448
  • [26] Updated 12-year results of a randomized clinical trial comparing standard-dose to high-dose myeloablative chemotherapy in the adjuvant treatment of breast cancer with more than three positive nodes (LN plus )
    Gianni, A. M.
    Bonadonna, G.
    Michelangelo, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] High-dose chemotherapy and autologous hematopoietic stem cell transplant for women with breast cancer and 10 or more involved axillary lymph nodes: Long-term follow-up
    Espinoza, A.
    Damon, L. E.
    Wolf, J. L.
    Rugo, H. S.
    Gold, E. O.
    Ries, C. A.
    Linker, C. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [28] Standard-dose versus high-dose radiotherapy with concurrent chemotherapy in esophageal cancer: A prospective randomized study
    Nayan, Navin
    Bhattacharyya, M.
    Jagtap, Vikas K.
    Kalita, A. K.
    Sunku, R.
    Roy, P. S.
    SOUTH ASIAN JOURNAL OF CANCER, 2018, 7 (01) : 27 - 30
  • [29] Long-term results of high-dose chemotherapy with autologous peripheral blood stem cell support as adjuvant treatment in breast cancer patients with more than 20 lymph nodes involvement
    Gullo, G.
    Bertuzzi, A.
    Collova, E.
    Castagna, L.
    Masci, G.
    Danova, M.
    Santoro, A.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S312 - S312
  • [30] High-dose chemotherapy with autologous stem cell transplantation in patients with oligometastatic breast cancer
    P Bojko
    A Welt
    R Schleucher
    D Borquez
    M E Scheulen
    U Vanhoefer
    C Poettgen
    M Stuschke
    C E Broelsch
    G Stamatis
    H Wilke
    S Seeber
    A Harstrick
    Bone Marrow Transplantation, 2004, 34 : 637 - 643
12345